These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6178808)
1. Axonal transport of muscarinic cholinergic receptors in rat vagus nerve: high and low affinity agonist receptors move in opposite directions and differ in nucleotide sensitivity. Zarbin MA; Wamsley JK; Kuhar MJ J Neurosci; 1982 Jul; 2(7):934-41. PubMed ID: 6178808 [TBL] [Abstract][Full Text] [Related]
6. Structure-linked latency of muscarinic receptors in axonal transport. Laduron PM; Scholtus T FEBS Lett; 1986 Sep; 206(1):83-6. PubMed ID: 2428662 [TBL] [Abstract][Full Text] [Related]
7. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. Ehlert FJ; Tran LP J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898 [TBL] [Abstract][Full Text] [Related]
8. Axonal transport of beta-adrenergic receptors. Antero- and retrogradely transported receptors differ in agonist affinity and nucleotide sensitivity. Zarbin MA; Palacios JM; Wamsley JK; Kuhar MJ Mol Pharmacol; 1983 Sep; 24(2):341-8. PubMed ID: 6193407 [TBL] [Abstract][Full Text] [Related]
9. Binding of agonists and antagonists to muscarinic acetylcholine receptors on intact cultured heart cells. Nathanson NM J Neurochem; 1983 Dec; 41(6):1545-9. PubMed ID: 6644298 [TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin. Larocca JN; Ledeen RW; Dvorkin B; Makman MH J Neurosci; 1987 Dec; 7(12):3869-76. PubMed ID: 3694257 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates. Lee JH; el-Fakahany EE J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264 [TBL] [Abstract][Full Text] [Related]
12. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Fisher SK Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485 [TBL] [Abstract][Full Text] [Related]
13. Parallel postnatal development of choline acetyltransferase activity and muscarinic acetylcholine receptors in the rat olfactory bulb. Large TH; Lambert MP; Gremillion MA; Klein WL J Neurochem; 1986 Mar; 46(3):671-80. PubMed ID: 3754001 [TBL] [Abstract][Full Text] [Related]
14. Distribution of muscarinic cholinergic high and low affinity agonist binding sites: a light microscopic autoradiographic study. Wamsley JK; Zarbin MA; Kuhar MJ Brain Res Bull; 1984 Mar; 12(3):233-43. PubMed ID: 6722598 [TBL] [Abstract][Full Text] [Related]
15. Influence of phospholipase C on muscarinic acetylcholine receptor binding in rat brain. Parthasarathy N; Pickard C; Aronstam RS Neurochem Res; 1984 May; 9(5):709-17. PubMed ID: 6472570 [TBL] [Abstract][Full Text] [Related]
16. Anterograde transport of opioid receptors in rat vagus nerves and dorsal roots of spinal nerves: pharmacology and sensitivity to sodium and guanine nucleotides. Zarbin MA; Wamsley JK; Kuhar MJ Exp Brain Res; 1990; 81(2):267-78. PubMed ID: 1697808 [TBL] [Abstract][Full Text] [Related]
17. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies. Cortés R; Palacios JM Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874 [TBL] [Abstract][Full Text] [Related]
18. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens. De Belleroche J; Kilpatrick IC; Birdsall NJ; Hulme EC Brain Res; 1982 Feb; 234(2):327-37. PubMed ID: 7059834 [TBL] [Abstract][Full Text] [Related]
19. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors. Baker SP; Posner P Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882 [TBL] [Abstract][Full Text] [Related]
20. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes. Sharif NA; Williams GW; DeSantis LM Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]